SCHEMBL28896332

SCHEMBL28896332

CCOC(=O)NC(=S)N(CCOC1CC1)c1cc[nH]c1C(=O)OCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
JAK3 P52333 2/20 0.34
JAK1 P23458 1/20 0.34
MAOA P21397 1/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 3/20 0.32
TDP1 Q9NUW8 1/20 0.32
POLB P06746 1/20 0.32
KMT2A Q03164 1/20 0.32
NUDT1 P36639 1/20 0.32
MAPT P10636 2/20 0.31
F2 P00734 1/20 0.31
GAA P10253 1/20 0.31
HTR1A P08908 1/20 0.31
DRD2 P14416 1/20 0.31
DRD4 P21917 1/20 0.31
HTR1D P28221 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21530683 0.84 KMT2A (0.39) CA12CA1CA2CA9MAOA
SCHEMBL34461784 0.82 RAB9A (0.39) CA12CA1CA2CA9KDM4E
SCHEMBL28896565 0.81 CA12 (0.31) CA12CA1CA2CA9
SCHEMBL28896615 0.81 CA12 (0.31) CA12CA1CA2CA9
SCHEMBL28896539 0.80 CA12 (0.30) CA12CA1CA2CA9
SCHEMBL29211265 0.79 CA12 (0.30) CA12CA1CA2CA9
SCHEMBL28896225 0.79 ADORA2B (0.31) KDM4E
SCHEMBL28896186 0.77 ADORA2B (0.30)
SCHEMBL28896496 0.76 ATM (0.34) JAK3JAK1MAPT
SCHEMBL28896526 0.76 MAPT (0.30) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115403584-B 2-thio-2, 3-dihydropyrimidine-4-one derivatives, pharmaceutical compositions, preparation methods and applications thereof 长春金赛药业有限责任公司 2024-04-02 CN disclosed
CN-115403584-A 2-thio-2, 3-dihydropyrimidine-4-one derivative, pharmaceutical composition, preparation method and application thereof 长春金赛药业有限责任公司 2022-11-29 CN disclosed